(Q53876627)

English

Insulin-like growth factor II mRNA-binding protein 3 (IMP3) expression in hepatocellular carcinoma. A clinicopathological analysis with emphasis on diagnostic value.

scientific article published in January 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

21 May 2018

http://europepmc.org/abstract/MED/22211286

Insulin-like growth factor II mRNA-binding protein 3 (IMP3) expression in hepatocellular carcinoma. A clinicopathological analysis with emphasis on diagnostic value. (English)

1 reference

Europe PubMed Central

PubMed publication ID

21 May 2018

http://europepmc.org/abstract/MED/22211286

1 reference

based on heuristic

inferred from title

5

1 reference

Europe PubMed Central

PubMed publication ID

21 May 2018

http://europepmc.org/abstract/MED/22211286

8

object named as

Arndt Hartmann

1 reference

Europe PubMed Central

PubMed publication ID

21 May 2018

http://europepmc.org/abstract/MED/22211286

author name string

David L Wachter

1

1 reference

Europe PubMed Central

PubMed publication ID

21 May 2018

http://europepmc.org/abstract/MED/22211286

Glen Kristiansen

2

1 reference

Europe PubMed Central

PubMed publication ID

21 May 2018

http://europepmc.org/abstract/MED/22211286

Christopher Soll

3

1 reference

Europe PubMed Central

PubMed publication ID

21 May 2018

http://europepmc.org/abstract/MED/22211286

Claus Hellerbrand

4

1 reference

Europe PubMed Central

PubMed publication ID

21 May 2018

http://europepmc.org/abstract/MED/22211286

Florian Fritzsche

6

1 reference

Europe PubMed Central

PubMed publication ID

21 May 2018

http://europepmc.org/abstract/MED/22211286

Abbas Agaimy

7

1 reference

Europe PubMed Central

PubMed publication ID

21 May 2018

http://europepmc.org/abstract/MED/22211286

Marc-Oliver Riener

9

1 reference

Europe PubMed Central

PubMed publication ID

21 May 2018

http://europepmc.org/abstract/MED/22211286

publication date

1 January 2012

1 reference

Europe PubMed Central

PubMed publication ID

21 May 2018

http://europepmc.org/abstract/MED/22211286

1 reference

Europe PubMed Central

PubMed publication ID

21 May 2018

http://europepmc.org/abstract/MED/22211286

60

1 reference

Europe PubMed Central

PubMed publication ID

21 May 2018

http://europepmc.org/abstract/MED/22211286

2

1 reference

Europe PubMed Central

PubMed publication ID

21 May 2018

http://europepmc.org/abstract/MED/22211286

278-286

1 reference

Europe PubMed Central

PubMed publication ID

21 May 2018

http://europepmc.org/abstract/MED/22211286

Management of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04091.X

21 January 2018

Value of glypican 3 immunostaining in the diagnosis of hepatocellular carcinoma on needle biopsy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04091.X

21 January 2018

Recent developments in liver pathology

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04091.X

21 January 2018

Immunohistochemical and molecular markers in the diagnosis of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04091.X

21 January 2018

Distinction of hepatocellular carcinoma from benign hepatic mimickers using Glypican-3 and CD34 immunohistochemistry

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04091.X

21 January 2018

External validation of IMP3 expression as an independent prognostic marker for metastatic progression and death for patients with clear cell renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04091.X

21 January 2018

Oncofetal protein IMP3: a novel molecular marker that predicts metastasis of papillary and chromophobe renal cell carcinomas

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04091.X

21 January 2018

IMP3 is a novel biomarker for adenocarcinoma in situ of the uterine cervix: an immunohistochemical study in comparison with p16(INK4a) expression

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04091.X

21 January 2018

Expression of a novel oncofetal mRNA-binding protein IMP3 in endometrial carcinomas: diagnostic significance and clinicopathologic correlations.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04091.X

21 January 2018

An oncofetal protein IMP3: a new molecular marker for the detection of esophageal adenocarcinoma and high-grade dysplasia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04091.X

21 January 2018

KOC (K Homology Domain Containing Protein Overexpressed in Cancer)

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04091.X

21 January 2018

IMP3 expression in lesions of the biliary tract: a marker for high-grade dysplasia and an independent prognostic factor in bile duct carcinomas

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04091.X

21 January 2018

IMP3 is a novel biomarker for triple negative invasive mammary carcinoma associated with a more aggressive phenotype

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04091.X

21 January 2018

RNA-binding protein insulin-like growth factor II mRNA-binding protein 3 expression promotes tumor invasion and predicts early recurrence and poor prognosis in hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04091.X

21 January 2018

Hepatocellular carcinoma: epidemiology and molecular carcinogenesis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04091.X

21 January 2018

Characterisation of the growth regulating gene IMP3, a candidate for Silver-Russell syndrome

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04091.X

21 January 2018

Cloning of a gene highly overexpressed in cancer coding for a novel KH-domain containing protein

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04091.X

21 January 2018

Expression of the highly conserved RNA binding protein KOC in embryogenesis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04091.X

21 January 2018

Nuclear transit of human zipcode-binding protein IMP1

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04091.X

21 January 2018

The RNA-binding protein IMP-3 is a translational activator of insulin-like growth factor II leader-3 mRNA during proliferation of human K562 leukemia cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04091.X

21 January 2018

RNA-binding IMPs promote cell adhesion and invadopodia formation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04091.X

21 January 2018

IMP3 distinguishes uterine serous carcinoma from endometrial endometrioid adenocarcinoma.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04091.X

21 January 2018

Representativity of TMA Studies

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2011.04091.X

21 January 2018

Identifiers

10.1111/J.1365-2559.2011.04091.X

1 reference

Europe PubMed Central

PubMed publication ID

21 May 2018

http://europepmc.org/abstract/MED/22211286

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

21 May 2018

http://europepmc.org/abstract/MED/22211286

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53876627&oldid=1879001241"